Neuroscience Market (Technology: Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neuroproteomics Analysis, Animal Behavior Analysis, Neuro-functional Analysis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20

Neuroscience Market (Technology: Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neuroproteomics Analysis, Animal Behavior Analysis, Neuro-functional Analysis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Neuroscience Market – Scope of Report

TMR’s report on the global neurosciences market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global neurosciences market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global neurosciences market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the neurosciences market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global neurosciences market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global neurosciences market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global neurosciences market.

The report delves into the competitive landscape of the global neurosciences market. Key players operating in the global neurosciences market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global neurosciences market profiled in this report.

Key Questions Answered in Global neurosciences Market Report
  • What is the sales/revenue generated by neurosciences across all regions during the forecast period?
  • What are the opportunities in the global neurosciences market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Neuroscience Market – Research Objectives and Research Approach

The comprehensive report on the global neurosciences market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global neurosciences market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global neurosciences market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Neuroscience Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neuroscience Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Neuroscience Market Analysis and Forecast, by Component
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2017–2031
6.3.1. Instrument
6.3.2. Software
6.3.3. Services
6.4. Market Attractiveness Analysis, by Component
7. Global Neuroscience Market Analysis and Forecast, by Technology
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017–2031
7.3.1. Whole Brain Imaging
7.3.2. Neuro-microscopy
7.3.3. Electrophysiology
7.3.4. Neuroproteomics Analysis
7.3.5. Animal Behavior Analysis
7.3.6. Neuro-functional Analysis
7.3.7. Others
7.4. Market Attractiveness Analysis, by Technology
8. Global Neuroscience Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Academic & Research Institutions
8.3.4. Others
8.4. Market Attractiveness Analysis, by Technology
9. Global Neuroscience Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Neuroscience Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Component, 2017–2031
10.3.1. Instrument
10.3.2. Software
10.3.3. Services
10.4. Market Value Forecast, by Technology, 2017–2031
10.4.1. Whole Brain Imaging
10.4.2. Neuro-microscopy
10.4.3. Electrophysiology
10.4.4. Neuroproteomics Analysis
10.4.5. Animal Behavior Analysis
10.4.6. Neuro-functional Analysis
10.4.7. Others
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Diagnostic Laboratories
10.5.3. Academic & Research Institutions
10.5.4. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Component
10.7.2. By Technology
10.7.3. By End-user
10.7.4. By Country
11. Europe Neuroscience Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Component, 2017–2031
11.3.1. Instrument
11.3.2. Software
11.3.3. Services
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. Whole Brain Imaging
11.4.2. Neuro-microscopy
11.4.3. Electrophysiology
11.4.4. Neuroproteomics Analysis
11.4.5. Animal Behavior Analysis
11.4.6. Neuro-functional Analysis
11.4.7. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Diagnostic Laboratories
11.5.3. Academic & Research Institutions
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Component
11.7.2. By Technology
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Neuroscience Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Component, 2017–2031
12.3.1. Instrument
12.3.2. Software
12.3.3. Services
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Whole Brain Imaging
12.4.2. Neuro-microscopy
12.4.3. Electrophysiology
12.4.4. Neuroproteomics Analysis
12.4.5. Animal Behavior Analysis
12.4.6. Neuro-functional Analysis
12.4.7. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Diagnostic Laboratories
12.5.3. Academic & Research Institutions
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Component
12.7.2. By Technology
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Neuroscience Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Component, 2017–2031
13.3.1. Instrument
13.3.2. Software
13.3.3. Services
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Whole Brain Imaging
13.4.2. Neuro-microscopy
13.4.3. Electrophysiology
13.4.4. Neuroproteomics Analysis
13.4.5. Animal Behavior Analysis
13.4.6. Neuro-functional Analysis
13.4.7. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Diagnostic Laboratories
13.5.3. Academic & Research Institutions
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Component
13.7.2. By Technology
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Neuroscience Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Component, 2017–2031
14.3.1. Instrument
14.3.2. Software
14.3.3. Services
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. Whole Brain Imaging
14.4.2. Neuro-microscopy
14.4.3. Electrophysiology
14.4.4. Neuroproteomics Analysis
14.4.5. Animal Behavior Analysis
14.4.6. Neuro-functional Analysis
14.4.7. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Diagnostic Laboratories
14.5.3. Academic & Research Institutions
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Component
14.7.2. By Technology
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. NEURALINK
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Kernel
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. BrainCo, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. MindMaze
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Paradromics
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. NeuroPro
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. NeuroSky
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. EMOTIV, Inc.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Cercare Medical A/S
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Plexon, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Noldus Information Technology B.V.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Femtonics Ltd.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. Neuralynx, Inc.
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview
15.3.14. Neurable, Inc.
15.3.14.1. Company Overview
15.3.14.2. Product Portfolio
15.3.14.3. SWOT Analysis
15.3.14.4. Financial Overview
15.3.14.5. Strategic Overview
15.3.15. Bitbrain Technologies
15.3.15.1. Company Overview
15.3.15.2. Product Portfolio
15.3.15.3. SWOT Analysis
15.3.15.4. Financial Overview
15.3.15.5. Strategic Overview
15.3.16. Halo Neuroscience
15.3.16.1. Company Overview
15.3.16.2. Product Portfolio
15.3.16.3. SWOT Analysis
15.3.16.4. Financial Overview
15.3.16.5. Strategic Overview
15.3.17. NeuroNexus Technologies, Inc.
15.3.17.1. Company Overview
15.3.17.2. Product Portfolio
15.3.17.3. SWOT Analysis
15.3.17.4. Financial Overview
15.3.17.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings